Trial Profile
Prospective study assessing effect of low fixed-doses combination Perindopril/Indapamide/Amlodipine in Grade 2 Hypertensives not Adequately Controlled
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jul 2019
Price :
$35
*
At a glance
- Drugs Amlodipine/indapamide/perindopril (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 24 Jun 2019 Results presented at the 29th European Meeting on Hypertension and Cardiovascular Protection
- 28 Jul 2018 New trial record
- 11 Jun 2018 Results presented at the 28th European Meeting on Hypertension and Cardiovascular Protection